Cytora, a clinical stage company developing unique stem cell treatments based on human Oral Mucosa Stem Cells (hOMSCs), reported today successful results of a Phase 1/2a clinical trial for treating ...

together with epithelial cell damage and chronic inflammation of the lamina propria. In biopsy samples from patients with collagenous colitis, a thickened layer of collagen can be seen beneath the ...